Skip to main content

Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Morgan Stanley Upgrades Bristol-Myers Squibb To Overweight, Raises PT To $34
Joe Young  
 
June 23, 2011 6:15am   Comments
Share:

Morgan Stanley has upgraded Bristol-Myers Squibb (NYSE: BMY) from Equal-weight to Overweight and has raised the price target from $28 to $34.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

 

Related Articles (BMY)

Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
Bristol-Myers Squibb Unusual Options Activity For July 31
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
Bristol Myers Cuts Earnings Outlook As Legacy Drugs Face Generic Erosion
Stock Market Today: S&P 500, Nasdaq To Open Higher After Robust Meta, Microsoft Earnings—Investors Await Apple, Amazon Results
Earnings Scheduled For July 31, 2025
View Comments and Join the Discussion!

Posted-In: bristol-myers squibb Morgan StanleyUpgrades Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com